## First-Line Antibiotic for Acute Bacterial Sinusitis **Key Point:** Amoxicillin-clavulanate is the preferred first-line empirical antibiotic for acute bacterial sinusitis in most guidelines, including EPOS (European Position on Rhinosinusitis) and American Academy of Otolaryngology. ### Rationale for Amoxicillin-Clavulanate **High-Yield:** The addition of clavulanate overcomes β-lactamase resistance produced by common pathogens: - *Streptococcus pneumoniae* - *Haemophilus influenzae* (non-typeable) - *Moraxella catarrhalis* These three organisms account for >90% of acute bacterial sinusitis cases. ### Dosing and Duration - **Dose:** 500 mg amoxicillin + 125 mg clavulanate, three times daily - **Duration:** 5–7 days (shorter courses are increasingly supported) - **Route:** Oral (adequate sinus penetration) ### When to Consider Alternatives | Scenario | Alternative | |----------|-------------| | Penicillin allergy (non-severe) | Cefuroxime axetil or cephalosporin | | Severe penicillin allergy (anaphylaxis) | Fluoroquinolone (levofloxacin) | | Treatment failure after 3–5 days | Fluoroquinolone or high-dose amoxicillin-clavulanate | | Immunocompromised host | Broader coverage; consider imaging | **Clinical Pearl:** Acute sinusitis is often viral; antibiotics are reserved for bacterial infection confirmed by purulent nasal discharge, fever, and imaging. Supportive care (saline irrigation, decongestants, NSAIDs) is first-line for viral rhinosinusitis. **Mnemonic:** **SHIP** — *Sinusitis, Haemophilus, Influenzae, Pneumococcus* — the three pathogens covered by amoxicillin-clavulanate. [cite:Park 26e Ch 4]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.